Arbutus Biopharma (ABUS) Exchange Rate Effect (2013 - 2026)
Arbutus Biopharma's (ABUS) quarterly Exchange Rate Effect came in at -$10000.0 in Q1 2026, down 350.0% year-on-year from $4000.0 in Q1 2025, and down 1100.0% quarter-over-quarter from $1000.0 in Q4 2025.
Arbutus Biopharma (ABUS) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Arbutus Biopharma has disclosed Exchange Rate Effect across 14 years of filings, most recently posting -$10000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$10000.0, down 350.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $14000.0 (up 128.57% YoY), and the FY2025 annual result was $14000.0, up 128.57% from the prior year.
- Exchange Rate Effect came in at -$10000.0 for Q1 2026 at Arbutus Biopharma, down from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $21000.0 in Q2 2025 to a low of -$33000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$1000.0 (2023), against an average of -$2800.0.
- Across the five-year window, Exchange Rate Effect soared 450.0% in 2023 and sank 700.0% in 2024, its largest moves.
- Arbutus Biopharma's Exchange Rate Effect stood at -$4000.0 in 2022, then jumped by 450.0% to $14000.0 in 2023, then sank by 335.71% to -$33000.0 in 2024, then surged by 103.03% to $1000.0 in 2025, then plunged by 1100.0% to -$10000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$10000.0 (Q1 2026), $1000.0 (Q4 2025), and -$12000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |